Comparative Pharmacology
Head-to-head clinical analysis: OMNIPAQUE 12 versus VARIBAR HONEY.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OMNIPAQUE 12 versus VARIBAR HONEY.
OMNIPAQUE 12 vs VARIBAR HONEY
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Radiopaque agent that attenuates X-rays, providing contrast in imaging. Iodine atoms absorb X-rays, enhancing visualization of blood vessels and tissues.
Barium sulfate is a radiopaque agent that absorbs x-rays, providing contrast in the gastrointestinal tract by coating the mucosal surface.
Adult dose: 12 g iodine (e.g., 200 mL of Omnipaque 12) administered intravenously, intra-arterially, or into body cavities. Typical contrast study dose: 1-2 mL/kg (max 150 mL) for CT; 40-60 mL for angiographic procedures.
Not applicable. Varibar Honey is a barium sulfate suspension for oral administration used as a contrast agent for GI imaging. No systemic dose; administered orally as directed by radiologist, typically 15-30 mL.
None Documented
None Documented
1-2 hours (normal renal function); prolonged to >20 hours in severe renal impairment (CrCl <30 mL/min)
Not applicable. As a non-absorbed contrast agent, it does not have a systemic half-life. The gastrointestinal transit time is approximately 1-2 hours for small bowel follow-through and up to 24 hours for colonic transit. Clinical relevance: absence of systemic absorption precludes elimination half-life.
Renal: >95% unchanged; biliary/fecal: <5%
Not applicable. VARIBAR HONEY is a non-absorbed barium sulfate suspension for oral or rectal administration. It is eliminated via fecal route: 100% unchanged in stool after gastrointestinal transit. No renal or biliary excretion occurs because the agent is not absorbed systemically.
Category C
Category C
Radiographic Contrast Agent
Radiographic Contrast Agent